BDNF and its receptors in human myasthenic thymus: Implications for cell fate in thymic pathology

被引:15
作者
Berzi, Angela [1 ]
Ayata, C. Korcan [2 ]
Cavalcante, Paola [1 ]
Falcone, Chiara [4 ]
Candiago, Elisabetta [5 ]
Motta, Teresio [5 ]
Bernasconi, Pia [1 ]
Hohlfeld, Reinhard [2 ,3 ]
Mantegazza, Renato [1 ]
Meinl, Edgar [3 ]
Farina, Cinthia [1 ,2 ]
机构
[1] Fdn IRCCS, Neurol Inst Carlo Besta, Neuroimmunol & Neuromuscular Disorders Unit, I-20133 Milan, Italy
[2] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany
[3] Univ Munich, Klinikum Grosshadern, Inst Clin Neuroimmunol, D-8000 Munich, Germany
[4] Fdn IRCCS, Neurol Inst Carlo Besta, Unit Neuroepidemiol, Milan, Italy
[5] Osped Riuniti Bergamo, Bergamo, Italy
关键词
neurotrophic factor; thymus; myasthenia gravis; germinal center; hyperplasia; thymonia;
D O I
10.1016/j.jneuroim.2008.04.019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Here we show that in myasthenic thymus several cell types, including thymic epithelial cells (TEC) and immune cells, were the source and the target of the neurotrophic factor brain-derived growth factor (BDNF). Interestingly, many actively proliferating medullary thymocytes expressed the receptor TrkB in vivo in involuted thymus, while this population was lost in hyperplastic or neoplastic thymuses. Furthermore, in hyperplastic thymuses the robust coordinated expression of BDNF in the germinal centers together with the receptor p75NTR on all proliferating B cells strongly suggests that this factor regulates germinal center reaction. Finally, all TEC dying of apoptosis expressed BDNF receptors, indicating that this neurotrophin is involved in TEC turnover. In thymomas both BDNF production and receptor expression in TEC were strongly hindered. This may represent an attempt of tumour escape from cell death. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:128 / 139
页数:12
相关论文
共 29 条
[1]
Besser M, 1999, J IMMUNOL, V162, P6303
[2]
Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system [J].
Bibel, M ;
Barde, YA .
GENES & DEVELOPMENT, 2000, 14 (23) :2919-2937
[3]
Myasthenia gravis: past, present, and future [J].
Conti-Fine, Bianca M. ;
Milani, Monica ;
Kaminski, Henry J. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (11) :2843-2854
[4]
The neurotrophin receptor p75NTR:: novel functions and implications for diseases of the nervous system [J].
Dechant, G ;
Barde, YA .
NATURE NEUROSCIENCE, 2002, 5 (11) :1131-1136
[5]
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB [J].
Douma, S ;
van Laar, T ;
Zevenhoven, J ;
Meuwissen, R ;
van Garderen, E ;
Peeper, DS .
NATURE, 2004, 430 (7003) :1034-1040
[6]
Massive lymphocyte apoptosis in the thymus of functionally deficient TrkB mice [J].
Garcia-Suarez, O ;
Blanco-Gelaz, MA ;
Lopez, ML ;
Germana, A ;
Cabo, R ;
Díaz-Esnal, B ;
Silos-Santiago, I ;
Ciriaco, E ;
Vega, JA .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 129 (1-2) :25-34
[7]
GarciaSuarez O, 1997, ANAT REC, V249, P226, DOI 10.1002/(SICI)1097-0185(199710)249:2<226::AID-AR9>3.0.CO
[8]
2-V
[9]
DISTRIBUTION OF NEUROTROPHIN RECEPTORS IN HUMAN PALATINE TONSILS - AN IMMUNOHISTOCHEMICAL STUDY [J].
HANNESTAD, J ;
LEVANTI, MB ;
VEGA, JA .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 58 (02) :131-137
[10]
Structure of nerve growth factor complexed with the shared neurotrophin receptor p75 [J].
He, XL ;
Garcia, KC .
SCIENCE, 2004, 304 (5672) :870-875